Summary & Overview
CPT 90868: Transcranial Magnetic Stimulation, Subsequent Session
CPT code 90868 covers the subsequent delivery and management of transcranial magnetic stimulation (TMS), a noninvasive neuromodulation therapy that uses magnetic fields to stimulate brain nerve cells and improve symptoms of depression. As TMS becomes more widely available, accurate coding of subsequent sessions is important for consistent claims processing and national billing visibility. This analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of what 90868 represents clinically and operationally, payer coverage considerations, typical sites of service, and common modifiers used with this type of service. The publication summarizes reimbursement benchmarks, utilization context, and recent policy updates affecting TMS delivery and billing where available. It also provides practical billing characteristics that payers and providers reference when submitting claims for subsequent TMS sessions. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 90868 describes the subsequent delivery and management of transcranial magnetic stimulation (TMS). This procedure uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression.
-
Service type: Repetitive transcranial magnetic stimulation (rTMS) therapy delivery and session management
-
Typical site of service: Outpatient behavioral health clinics, psychiatric centers, or ambulatory procedure suites where TMS devices are available
Clinical & Coding Specifications
Clinical Context
A 42-year-old patient with treatment-resistant major depressive disorder presents to an outpatient psychiatric specialty clinic for ongoing transcranial magnetic stimulation (TMS) therapy. The patient previously completed a course of daily TMS sessions with documented partial response and is scheduled for subsequent, maintenance or continuation TMS sessions. Before each session, a trained clinician or technician conducts a brief pre-treatment assessment including suicidal ideation screen, medication review, and device safety check. The patient is positioned in a dedicated TMS suite or outpatient procedural room; the provider programs the TMS device parameters, confirms coil placement over the targeted dorsolateral prefrontal cortex, and delivers a session of repetitive stimulation while monitoring tolerance and side effects. Post-session, the patient is observed briefly for headache or discomfort, counseled on expected transient adverse effects, and scheduled for the next session. Clinical documentation includes indication, session number, device settings, coil positioning, patient tolerance, and any complications. Billing for subsequent delivery and management of TMS per session is reported with 90868.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a medically necessary E/M is performed and documented on the same day as a TMS session and is above and beyond routine pre-procedure checks. |